|
Market Closed -
Nasdaq
16:00:00 2026-10-16 EDT
|
5-day change | 1st Jan Change | ||
| 2.570 USD | -3.75% |
|
-26.78% | +80.99% |
| 10-15 | Edesa Biotech, Inc. Receives FDA IND Clearance For Phase 2 Clinical Study Of EB06 In Vitiligo | CI |
| 08-19 | Edesa Biotech Launches Public Offering of Common Shares, Warrants | MT |
Chart calendar Edesa Biotech, Inc.
Upcoming events on Edesa Biotech, Inc.
No events available
Past events on Edesa Biotech, Inc.
| 2026-05-27 | Annual General Meeting | 10:30 |
Annual results
| Fiscal Period | September | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 23,3 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -9,22 -9,03 -2.11% | -7,01 -8,40 16.49% | -7,91 -7,41 -6.72% | -17,9 | -24,1 | -32,9 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -8,37 -8,84 5.24% | -6,17 -7,60 18.83% | -7,18 -6,85 -4.86% | -17,5 | -23,9 | -32,6 |
|
Net income Million USD | Released Forecast Spread | -8,37 -8,85 5.32% | -6,17 -7,60 18.82% | -7,19 -6,85 -4.86% | -17,5 | -23,9 | -32,6 |
|
EPS USD | Released Forecast Spread | -2,93 -3,09 5.18% | -1,93 -2,16 10.44% | -1,27 -1,17 -8.55% | -1,99 | -2,07 | -2,05 |
| Announcement Date | 15/12/23 | 13/12/24 | 12/12/25 | - |
Quarterly results
| Fiscal Period | June | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 | 2027 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -1,90 -1,20 -58.22% | -1,64 -1,80 8.95% | -1,90 -1,82 -4.79% | -2,47 -2,00 -23.51% | -2,34 -4,00 41.47% | -4,30 -2,20 -95.32% | -5,52 -4,01 -37.78% | -5,75 | ||||
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -1,62 -1,00 -61.73% | -1,59 -1,70 6.49% | -1,75 -1,68 -3.93% | -2,23 -1,90 -17.28% | -2,25 -3,80 40.85% | -4,22 -2,15 -96.16% | -5,41 -3,92 -37.91% | -5,64 | ||||
|
Net income Million USD | Released Forecast Spread | -1,62 -1,00 -61.73% | -1,59 -1,70 6.44% | -1,75 -1,68 -3.93% | -2,23 -1,90 -17.28% | -2,25 -3,80 40.85% | -4,22 -2,15 -96.2% | -5,41 -3,92 -37.91% | -5,64 | ||||
|
EPS USD | Released Forecast Spread | -0,48 -0,31 -54.84% | -0,30 -0,30 -1.69% | -0,25 -0,26 5.06% | -0,32 -0,27 -20% | -0,28 -0,45 37.78% | -0,49 -0,26 -88.46% | -0,60 -0,44 -37.93% | -0,58 | ||||
| Announcement Date | 14/02/25 | 14/05/25 | 08/08/25 | 12/12/25 | 13/02/26 | 14/05/26 | 13/08/26 | - | - | - | - | - |
| 2026-10-21 |  | Information meeting | 09:00 |
| 2026-10-22 | | Earnings release - Q3 2026 | |
| 2026-10-22 | | Earnings presentation | 08:30 |
| 2026-10-23 | | Extraordinary General Meeting | 02:00 |
| 2026-10-25 | | Board of Directors Meeting | |
| 2026-10-25 | | Board of Directors Meeting | |
| 2026-10-26 | | Earnings release - Q3 2026 | |
| 2026-10-26 | | Earnings release - Q3 2026 | |
| 2026-10-26 | | Présentation aux Actionnaires / Analystes | |
| 2026-10-27 | | Earnings release - Q3 2026 |
Past sector events for Edesa Biotech, Inc.
| 2026-10-14 | | Information meeting | 14:30 |
| 2026-10-14 | | Présentation aux Actionnaires / Analystes | |
| 2026-10-14 | | Sales and Revenue Release - Q3 2026 | |
| 2026-10-14 | | Information meeting | 08:00 |
| 2026-10-13 | | Présentation aux Actionnaires / Analystes | |
| 2026-10-13 | | Information meeting | 16:30 |
| 2026-10-13 | | Extraordinary General Meeting | 22:00 |
| 2026-10-07 | | Extraordinary General Meeting | 09:00 |
| 2026-10-07 | | Présentation aux Actionnaires / Analystes | 09:00 |
| 2026-10-06 | | Information meeting | 10:00 |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Stocks
- EDSA Stock
- Calendar Edesa Biotech, Inc.
Select your edition
All financial news and data tailored to specific country editions
